The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Blood‐Brain Barrier Permeable Gold Nanoparticles: An Efficient Delivery Platform for Enhanced Malignant Glioma Therapy and Imaging
Open accessAbstract
The blood‐brain barrier (BBB) remains a formidable obstacle in medicine, preventing efficient penetration of chemotherapeutic and diagnostic agents to malignant gliomas. Here, a transactivator of transcription (TAT) peptide‐modified gold nanoparticle platform (TAT‐Au NP) with a 5 nm core size is demonstrated to be capable of crossing the BBB efficiently and delivering cargoes such as the anticancer drug doxorubicin (Dox) and Gd 3+ contrast agents to brain tumor tissues. Treatment of mice bearing intracranial glioma xenografts with pH‐sensitive Dox‐conjugated TAT‐Au NPs via a single intravenous administration leads to significant survival benefit when compared to the free Dox. Furthermore, it is demonstrated that TAT‐Au NPs are capable of delivering Gd 3+ chelates for enhanced brain tumor imaging with a prolonged retention time of Gd 3+ when compared to the free Gd 3+ chelates. Collectively, these results show promising applications of the TAT‐Au NPs for enhanced malignant brain tumor therapy and non‐invasive imaging.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
Stupp, R., Hegi, M. E., Mason, W. P., van den Bent, M. J., Taphoorn, M. J., Janzer, R. C., Ludwin, S. K., Allgeier, A., Fisher, B., Belanger, K., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70025-7 · Cited by 7,668
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
Grauer, O. M., Wesseling, P., & Adema, G. J. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00315.x · Cited by 4,007
Wen, P. Y., & Kesari, S. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0708126 · Cited by 3,511
Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438
In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse
Schwarze, S. R., Ho, A., Vocero-Akbani, A., & Dowdy, S. F. (1999) · Science · doi:10.1126/science.285.5433.1569 · Cited by 2,416
Dysregulated pH: a perfect storm for cancer progression
Webb, B. A., Chimenti, M., Jacobson, M. P., & Barber, D. L. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3110 · Cited by 2,237
Nanoparticle PEGylation for Imaging and Therapy
Jokerst, J. V., Lobovkina, T., Zare, R. N., & Gambhir, S. S. (2011) · Nanomedicine · doi:10.2217/nnm.11.19 · Cited by 2,046
Lewin, M., Carlesso, N., Tung, C.-H., Tang, X.-W., Cory, D., Scadden, D. T., & Weissleder, R. (2000) · Nature Biotechnology · doi:10.1038/74464 · Cited by 1,716
Particle size-dependent organ distribution of gold nanoparticles after intravenous administration
De Jong, W. H., Hagens, W. I., Krystek, P., Burger, M. C., Sips, A. J. A. M., & Geertsma, R. E. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.12.037 · Cited by 1,615
Jain, R. K., di Tomaso, E., Duda, D. G., Loeffler, J. S., Sorensen, A. G., & Batchelor, T. T. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2175 · Cited by 1,405
Extinction coefficient of gold nanoparticles with different sizes and different capping ligands
Liu, X., Atwater, M., Wang, J., & Huo, Q. (2007) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2006.08.005 · Cited by 1,379
Sonavane, G., Tomoda, K., & Makino, K. (2008) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2008.07.004 · Cited by 1,100
Temozolomide and treatment of malignant glioma
Friedman, H. S., Kerby, T., & Calvert, H. (2000) · PubMed · doi:10.25405/ncl.34644405 · Cited by 731
Lee, C. C., Gillies, E. R., Fox, M. E., Guillaudeu, S. J., Fréchet, J. M. J., Dy, E. E., & Szoka, F. C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607705103 · Cited by 650
Spherical Nucleic Acid Nanoparticle Conjugates as an RNAi-Based Therapy for Glioblastoma
Jensen, S. A., Day, E. S., Ko, C. H., Hurley, L. A., Luciano, J. P., Kouri, F. M., Merkel, T. J., Luthi, A. J., Patel, P. C., Cutler, J. I., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006839 · Cited by 592
Yuan, H., Fales, A. M., & Vo-Dinh, T. (2012) · Journal of the American Chemical Society · doi:10.1021/ja304180y · Cited by 523
Wiley, D. T., Webster, P., Gale, A., & Davis, M. E. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307152110 · Cited by 519
Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis.
Arola, O., Saraste, A., Pulkki, K. J., Kallajoki, M. A., Parvinen, M., & Voipio-Pulkki, L. M. (2000) · PubMed · Cited by 494
Ruan, G., Agrawal, A., Marcus, A. I., & Nie, S. (2007) · Journal of the American Chemical Society · doi:10.1021/ja074936k · Cited by 483
Active targeting of brain tumors using nanocarriers
Béduneau, A., Saulnier, P., & Benoit, J.-P. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.06.011 · Cited by 424
Liu, Y., Shipton, M. K., Ryan, J., Kaufman, E. D., Franzen, S., & Feldheim, D. L. (2007) · Analytical Chemistry · doi:10.1021/ac061578f · Cited by 369
Lysosomes as Targets for Cancer Therapy
Fehrenbacher, N., & Jäättelä, M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0476 · Cited by 324
Sarin, H., Kanevsky, A. S., Wu, H., Brimacombe, K. R., Fung, S. H., Sousa, A. A., Auh, S., Wilson, C. M., Sharma, K., Aronova, M. A., et al. (2008) · Journal of Translational Medicine · doi:10.1186/1479-5876-6-80 · Cited by 274
Liu, L., Guo, K., Lu, J., Venkatraman, S. S., Luo, D., Ng, K. C., Ling, E.-A., Moochhala, S., & Yang, Y.-Y. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.11.014 · Cited by 246
Targeted therapy for brain tumours
Lesniak, M. S., & Brem, H. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1414 · Cited by 234
Self-citationNanobiotechnology-Based Strategies for Crossing The Blood–Brain Barrier
Jain, K. K. (2012) · Nanomedicine · doi:10.2217/nnm.12.86 · Cited by 233
Aryal, S., Grailer, J. J., Pilla, S., Steeber, D. A., & Gong, S. (2009) · Journal of Materials Chemistry · doi:10.1039/b914071a · Cited by 226
Rapid and effective labeling of brain tissue using TAT-conjugated CdS∶Mn/ZnS quantum dots
Santra, S., Yang, H., Stanley, J. T., Holloway, P. H., Moudgil, B. M., Walter, G., & Mericle, R. A. (2005) · Chemical Communications · doi:10.1039/b503234b · Cited by 215
Multimodal Gadolinium‐Enriched DNA–Gold Nanoparticle Conjugates for Cellular Imaging
Song, Y., Xu, X., MacRenaris, K. W., Zhang, X., Mirkin, C. A., & Meade, T. J. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200904666 · Cited by 196
Yan, H., Wang, L., Wang, J., Weng, X., Lei, H., Wang, X., Jiang, L., Zhu, J., Lu, W., Wei, X., et al. (2012) · ACS Nano · doi:10.1021/nn203749v · Cited by 191
In vivo assembly of nanoparticle components to improve targeted cancer imaging
Perrault, S. D., & Chan, W. C. W. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001367107 · Cited by 181
Polymeric micelles anchored with TAT for delivery of antibiotics across the blood–brain barrier
Liu, L., Venkatraman, S. S., Yang, Y. Y., Guo, K., Lu, J., He, B., Moochhala, S., & Kan, L. (2008) · Biopolymers · doi:10.1002/bip.20998 · Cited by 155
Recent Advances in Brain Tumor Therapy: Local Intracerebral Drug Delivery by Polymers
Guérin, C. J., Olivi, A., WEINGART, J. D., Lawson, H. C., & Brem, H. (2003) · Investigational New Drugs · doi:10.1023/b:drug.0000006172.65135.3e · Cited by 153
Qin, Y., Chen, H., Zhang, Q., Wang, X., Yuan, W., Kuai, R., Tang, J., Zhang, L., Zhang, Z., Zhang, Q., et al. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.09.008 · Cited by 152
Self-citationLocal delivery of doxorubicin for the treatment of malignant brain tumors in rats.
Lesniak, M. S., Upadhyay, U. M., Goodwin, R. M., Tyler, B., & Brem, H. (2005) · PubMed · Cited by 152
Self-citationEffect of Concentration on the Cytotoxic Mechanism of Doxorubicin—Apoptosis and Oxidative DNA Damage
Müller, I., Jenner, A. M., Bruchelt, G., NIETHAMMER, D., & Halliwell, B. B. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.5898 · Cited by 145
Negotiation of Intracellular Membrane Barriers by TAT-Modified Gold Nanoparticles
Krpetić, Ž., Saleemi, S., Prior, I. A., Sée, V., Qureshi, R., & Brust, M. (2011) · ACS Nano · doi:10.1021/nn201369k · Cited by 142
Cheng, Y., Meyers, J. D., Agnes, R. S., Doane, T. L., Kenney, M. E., Broome, A., Burda, C., & Basilion, J. P. (2011) · Small · doi:10.1002/smll.201100628 · Cited by 130
Self-citationEtame, A. B., Smith, C. A., Chan, W. C. W., & Rutka, J. T. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.04.004 · Cited by 125
Frigell, J., Garcı́a, I., Gómez‐Vallejo, V., Llop, J., & Penadés, S. (2013) · Journal of the American Chemical Society · doi:10.1021/ja411096m · Cited by 118
Yang, C., & Chuang, K. (2012) · MedChemComm · doi:10.1039/c2md00279e · Cited by 109
Biomedicine: The new gold standard
Weintraub, K. (2013) · Nature · doi:10.1038/495s14a · Cited by 80
Synthesis and visualization of a membrane-permeable MRI contrast agent
Allen, M. J., & Meade, T. J. (2003) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-003-0475-2 · Cited by 71
Raza, S. M., Pradilla, G., Legnani, F. G., Thai, Q. A., Olivi, A., WEINGART, J. D., & Brem, H. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.4.477 · Cited by 41
Cited by
Crossing the blood-brain barrier with nanoparticles
Zhou, Y., Peng, Z., Seven, E. S., & Leblanc, R. M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.015 · Cited by 837
Nanoparticles in Daily Life: Applications, Toxicity and Regulations
Gupta, R., & Xie, H. (2018) · Journal of Environmental Pathology, Toxicology and Oncology · doi:10.1615/jenvironpatholtoxicoloncol.2018026009 · Cited by 553
Nanoparticles and targeted drug delivery in cancer therapy
Bahrami, B., Hojjat-Farsangi, M., Mohammadi, H., Anvari, E., Ghalamfarsa, G., Yousefi, M., & Jadidi-Niaragh, F. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.07.015 · Cited by 510
Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications
Spicer, C. D., Jumeaux, C., Gupta, B., & Stevens, M. M. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00877e · Cited by 497
Progress and perspectives on targeting nanoparticles for brain drug delivery
Gao, H. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.05.013 · Cited by 495
Metadata
- Authors
- Cheng, Y., Dai, Q., Morshed, R. A., Fan, X., Wegscheid, M. L., Wainwright, D. A., Han, Y., Zhang, L., Auffinger, B., Tobias, A. L., Rincón, E., Thaci, B., Ahmed, A. U., Warnke, P. C., He, C., & Lesniak, M. S.
- Venue
- Small
- Publisher
- Wiley
- Published
- 2014-08-08
- Volume
- 10
- Issue
- 24
- Pages
- 5137-5150
- ISSN
- 1613-6810 (ISSN-L)
- 1613-6829
- OpenAlex
- W2108294913
- Cited by
- 271
- References
- 46
- FWCI
- 6.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.